J&J COVID-19 Vaccine Update, April 13, 2021
The use of this vaccine is ‘paused’ for now. This is because the safety systems that make sure vaccines are safe received a small number of reports of a rare and severe type of blood clot happening in people who got this vaccine.
We do not know enough yet to say if the vaccine is related to or caused this health issue. To be extra careful, CDC and FDA recommend that the vaccine not be given until we learn more.
If you got this vaccine, seek medical care urgently if you develop any of the following symptoms:
- severe headache
- backache
- new neurologic symptoms
- severe abdominal pain
- shortness of breath
- leg swelling
- tiny red spots on the skin (petechiae), or
- new or easy bruising
A pause in the use of Johnson & Johnson’s Janssen (J&J/Janssen) COVID-19 Vaccine. This means that CDC and FDA recommend this vaccine not be given to anyone until we know more. This gives scientists a chance to review the data and decide if recommendations on who should get the vaccine need to change. CDC and FDA will share more information as soon as possible with healthcare providers, people who got the vaccine, and the public.
From their review, they saw a small number of cases of a rare and severe type of blood clot in people who got the J&J/Janssen COVID-19 Vaccine. All reported cases were in women between the ages of 18 and 48, and the problems were found up to two weeks after vaccination.
